A 19-year-old girl referred to a hospital for flank pain and urinary symptoms and was treated with ceftriaxone with a pyelonephritis diagnosis. The patient was subjected to neurological consultation given the chronic use of neuroleptic drugs, including nortriptyline 10 mg every 8 hours, olanzapine 5 mg twice a day, and biperidin 1/2 twice a day, and daily cabergoline. The patient's history showed recurrent chronic abdominal pain once or twice every two to three days from 12 years ago. The patient reported that, according to the above symptoms, she was treated with the diagnosis of irritable bowel syndrome with pantoprazole 20 mg on fasting, clinidium-c every 8 hours, and ranitidine 50 every 12 hours under gastric counseling. According to the patient's history, due to the above complaints (i.e., repetitive abdominal pain, recurring every 2 to 3 days several times a day taking a few minutes each time), she had repeatedly referred to internal diseases specialists and general physicians during the course of about 12 years. Thus, several diagnostic tests were conducted, which include the followings according to the available evidence:
Endoscopy, abdominal and pelvic ultrasonography, amylase and lipase levels, CBC, ALT, and AST were reported as normal. WBC was high in urine analysis, and E. coli was observed in the UC test. In the neurological examinations performed at the time of the patient’s pain, she had complete temporal and spatial orientation; cranial nerves, reflexes, cerebellar tests, and sensory tests were normal. The patient had been under psychiatric counseling for about 10 years, whereby she received nortriptyline, olanzapine, and biperidin. As the abdominal pain attacks were not controlled, pantoprazole, clindium C, and ranitidine were added to the treatment course, which proved ineffective on the recovery of abdominal pain. The patient was diagnosed with galactorrhea from about two years ago, whereby a prolactin level of 74 was recorded by the treating physician. A brain MRI was also performed with a normal report whereby pituitary microadenoma was diagnosed, and cabergoline was initiated on a daily basis.
In the recent visit, given the chronic use of neuroleptic drugs and continued abdominal pain, a neurological consultation was requested, whereby complete history was taken upon suspected abdominal epilepsy or migraine. The history showed that, along with abdominal pain, the patient suffered from occasional dizziness attacks and transient disconnection with the environment, but there were no signs suggesting migraine headaches. Upon suspected abdominal epilepsy in the neurological examination, electroencephalography was performed, which showed seizure waves predominantly spike and sharp waves reflecting the temporal lobe focus, suggesting seizure diagnosis for the patient. Carbamazepine was started twice daily. After 10 days of follow-up, a large part of the abdominal pain attacks was controlled. Olanzapine, nortriptyline, ranitidine, clidinium-c, and pantoprazole C were discontinued. After two months, prolactin was found at a normal level and cabergoline was discontinued.